Pharmaceutical industry relieved as drugs excluded from tariffs

US excludes pharmaceuticals from reciprocal tariffs on South Korea. Korean pharma stocks rise slightly. Separate drug tariffs still possible in future.

GC Green Cross's 'Hunterase' confirms efficacy in Phase 3

GC Green Cross's Hunter syndrome treatment 'Hunterase' showed significant improvement in patient mobility and organ function in Phase 3 clinical trials, as published in 'Genetics in Medicine'.

GC Green Cross presents immunoglobulin thrombosis research at ISTH 2025

GC Green Cross presented research on immunoglobulin viscosity at ISTH 2025, suggesting room temperature administration may reduce thrombosis risk. The study compared viscosity of five products across temperatures.